Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · April 16, 2023

Efficacy of Alternative Dosing Regimens of Exemestane in Postmenopausal Women With ER+ Breast Cancer

JAMA Oncology

 

Additional Info

JAMA Oncology
Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial
JAMA Oncol 2023 Mar 23;[EPub Ahead of Print], D Serrano, S Gandini, P Thomas, KD Crew, NB Kumar, LA Vornik, JJ Lee, P Veronesi, G Viale, A Guerrieri-Gonzaga, M Lazzeroni, H Johansson, M D'Amico, F Guasone, S Spinaci, BE Bertelsen, G Mellgren, I Bedrosian, D Weber, T Castile, E Dimond, BM Heckman-Stoddard, E Szabo, PH Brown, A DeCensi, B Bonanni

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading